Anti-CD70 UCAR-T

· Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD70 UCAR-T, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors [Phase 1]